SPINK1 and prostate carcinoma: In a SPINK1-positive prostate cancer mouse model, cancer-associated mortalities were confirmed and miRNA-338-5p/-421 abrogated oncogenic effects including cell-cycle progression, stemness, metastasis and drug resistance [31].